RISK ASSESSMENTS/RISK MANAGEMENT FOR ENVIRONMENTAL USES OF BIOLOGICAL AGENTS
Notice - This site contains archived material(s)
Archive disclaimer
Archive
disclaimer
Archived files are provided for reference
purposes only. These files are no longer maintained by the Agency and may be outdated. For
current EPA information, go to www.epa.gov. It is EPA's policy to
support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation
Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact
EPA's Reasonable Accommodations
or submit a request using the Contact Us form.
Abstract
Through recent advances in molecular biology, especially biotechnology, regulatory agencies are faced with evaluating a range of biological agents for potential risks they pose to human health and the environment. Although biological risks are of relatively recent concern, this has not been the case for chemicals. Over the past several years, the Environmental Protection Agency (EPA) has developed methodologies for assessing health risks associated with chemical pollutants, especially chemical carcinogens. In anticipation of regulating biological agents, including genetically engineered microorganisms, the Agency must stimulate the generation of a solid scientific basis in order to adapt its present, chemically based risk assessment approaches to biological agents. Assessing biological risk poses unique problems owing to the diversity (hormones, enzymes, bacteria, fungi, viruses, plasmids) and the ability of live molecules to replicate, transform, transduce, and infect.
Citation
Anderson, E., R. Albert, AND D. Kamely. RISK ASSESSMENTS/RISK MANAGEMENT FOR ENVIRONMENTAL USES OF BIOLOGICAL AGENTS. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/D-85/285 (NTIS PB86131810), 1985.
Additional Information
Prepared in cooperation with New York Univ. Medical Center, NY.